Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chawla S et al. – SBRT for adrenal metastases is well tolerated. Most patients developed widespread metastases shortly after treatment. Local control was poor, although this was a patient population selected for adverse risk factors, such as bulky disease. Additional studies are needed to determine the efficacy of SBRT for oligometastatic adrenal metastases, given the propensity of these patients to develop further disease progression.


Today in Adrenal Glands...keeping you current

The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09

Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09

Adrenal insufficiency in acute coronary syndrome
Singapore Medical Journal, 11/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address